JUBILANT INGREVIA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 544.1 INR | -2.87% |
|
+1.16% | +6.98% |
| Apr. 26 | Jubilant Ingrevia Raises INR1 Billion Via Commercial Paper Issue | MT |
| Apr. 17 | Jubilant Ingrevia Issues Commercial Papers Worth INR1 Billion | MT |
| Sales 2024 * | 41B 492M | Sales 2025 * | 50.59B 607M | Capitalization | 86.66B 1.04B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.91B 22.93M | Net income 2025 * | 2.98B 35.68M | EV / Sales 2024 * | 2.11 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.71 x |
| P/E ratio 2024 * |
43
x | P/E ratio 2025 * |
27
x | Employees | 2,295 |
| Yield 2024 * |
0.74% | Yield 2025 * |
0.82% | Free-Float | 42.9% |
More Fundamentals
* Assessed data
More news
Latest transcript on Jubilant Ingrevia Limited
| 1 day | -2.87% | ||
| 1 week | +1.16% | ||
| Current month | +20.19% | ||
| 1 month | +19.29% | ||
| 3 months | +17.10% | ||
| 6 months | +26.93% | ||
| Current year | +6.98% |
1 week
534.85
581.70
1 month
440.30581.70
Current year
420.00581.70
1 year
379.05581.70
3 years
320.25838.75
5 years
241.30838.75
10 years
241.30838.75
| Managers | Title | Age | Since |
|---|---|---|---|
Deepak Jain
CEO | Chief Executive Officer | - | 23-09-30 |
| Chief Executive Officer | 60 | 98-07-12 | |
| Director of Finance/CFO | 35 | 21-02-15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 67 | 21-02-05 | |
| Chairman | 71 | 21-02-05 | |
| Director/Board Member | 46 | 21-02-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 117 M€ | +1.11% | - | |
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 544.1 | -2.87% | 352,285 |
| 24-04-25 | 560.2 | +0.85% | 538,935 |
| 24-04-24 | 555.4 | +3.52% | 3,092,244 |
| 24-04-23 | 536.6 | -0.70% | 351,315 |
| 24-04-22 | 540.4 | +0.46% | 639,186 |
Delayed Quote NSE India S.E., April 26, 2024 at 07:43 am EDT
More quotes
Jubilant Ingrevia Limited is an India-based integrated provider of life sciences products and solutions. The Company's segments include Speciality Chemicals, Nutrition and Health Solutions, and Chemical Intermediates. The Speciality Chemicals segment includes pyridine and picolines, fine chemicals, agro chemicals, and custom development and manufacturing organization. The Nutrition and Health Solutions segment includes nutrition and health ingredients, and animal and human nutrition health solutions. The Chemical Intermediates segment includes acetyls and speciality ethanol. Its agro chemicals business is focused on agro intermediates and agro actives, including insecticides, herbicides and fungicides. Its range of products includes nutritional ingredients, such as vitamin B3, vitamin B4, picolinates and premix formulations for both animal and human nutrition. The Company serves various industries, such as pharmaceutical, nutrition, agrochemical, consumer and industrial customers.
Sector
Specialty Chemicals
Calendar
2024-05-13
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
544.1
INR
Average target price
557.3
INR
Spread / Average Target
+2.43%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.98% | 1.04B | |
| +11.47% | 63.22B | |
| -3.47% | 46.34B | |
| +13.72% | 39.97B | |
| +17.83% | 25.46B | |
| +7.27% | 18.68B | |
| -0.57% | 17.24B | |
| -21.73% | 15.81B | |
| +0.22% | 14.9B | |
| -19.10% | 13.74B |
- Stock Market
- Equities
- JUBLINGREA Stock
